Background: This study aimed to identify factors predicting the recoverability of renal function after pyeloplasty in adult patients with ureteropelvic junction obstruction. Methods: We retrospectively reviewed 138 adults with unilateral renal obstruction-induced hydronephrosis and who underwent Anderson-Hynes dismembered pyeloplasty from January 2013 to January 2016. Hydronephrosis was classified preoperatively according to the Society for Fetal Urology (SFU) grading system. All patients underwent Doppler ultrasonography, excretory urography, computed tomography, and technetium-99m-diethylenetriamine pentaacetic acid radioisotope (99mTc DTPA) renography before and after surgery. Renal resistive index (RRI) and 99mTc DTPA renography were repeated at 1, 3, 6, and 12 months. Results: Multivariate analysis identified age, renal pelvic type, SFU grade, preoperative RRI, decline of RRI, and renal parenchyma to hydronephrosis area ratio (PHAR) as independent predictors of renal function recoverability after pyeloplasty. However, preoperative RRI and RRI decline were not significantly associated with recoverability of renal function in patients aged >35 years. Lower preoperative RRI, greater decline in RRI, higher PHAR, lower SFU grade, and extrarenal pelvis were associated with greater improvements in postoperative renal function. Conclusions: Preoperative differential renal function cannot independently predict the recoverability of postoperative renal function in adult patients with unilateral renal obstruction-induced hydronephrosis. SFU grade, renal pelvic type, PHAR, preoperative RRI, and decline in RRI were significantly associated with the recoverability of renal function in adult patients aged <35 years, while only SFU grade, renal pelvic type, and PHAR were significantly associated with renal function recoverability in patients aged ≥35 years. Renal function recovery was better in patients younger than 35 years when compared with older patients.

Keywords:
Pyeloplasty, Ureteropelvic junction obstruction, Recoverability, Predictor, Renal function
1.
Zhang S, Zhang Q, Ji C, Zhao X, Liu G, Zhang S, Li X, Lian H, Zhang G, Guo H: Improved split renal function after percutaneous nephrostomy in young adults with severe hydronephrosis due to ureteropelvic junction obstruction. J Urol 2015; 193: 191–195.
2.
Mesrobian HG, Mirza SP: Hydronephrosis: a view from the inside. Pediatr Clin North Am 2012; 59: 839–851.
3.
Aziz MA, Hossain AZ, Banu T, Karim MS, Islam N, Sultana H, Alam MI, Hanif A, Khan AR: In hydronephrosis less than 10 % kidney function is not an indication for nephrectomy in children. Eur J Pediatr Surg 2002; 12: 304–307.
4.
Gupta DK, Chandrasekharam VV, Srinivas M, Bajpai M: Percutaneous nephrostomy in children with ureteropelvic junction obstruction and poor renal function. Urology 2001; 57: 547–550.
5.
Xu N, Chen SH, Xue XY, Zheng QS, Wei Y, Jiang T, Li XD, Huang JB, Cai H: Comparison of retrograde balloon dilatation and laparoscopic pyeloplasty for treatment of ureteropelvic junction obstruction: results of a 2-year follow-up. PLoS One 2016; 11:e0152463.
6.
Garg RK, Menon P, Narasimha Rao KL, Arora S, Batra YK: Pyeloplasty for hydronephrosis: issues of double J stent versus nephrostomy tube as drainage technique. J Indian Assoc Pediatr Surg 2015; 20: 32–36.
7.
Tomaszewski JJ, Cung B, Smaldone MC, Mehrazin R, Kutikov A, Viterbo R, Chen DY, Greenberg RE, Uzzo RG: Renal pelvic anatomy is associated with incidence, grade, and need for intervention for urine leak following partial nephrectomy. Eur Urol 2014; 66: 949–955.
8.
Tomaszewski JJ, Smaldone MC, Cung B, Li T, Mehrazin R, Kutikov A, Canter DJ, Viterbo R, Chen DY, Greenberg RE, Uzzo RG: Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy. Urology 2014; 84: 351–357.
9.
Kim DS, Cho KS, Lee YH, Cho NH, Oh YT, Hong SJ: High-grade hydronephrosis predicts poor outcomes after radical cystectomy in patients with bladder cancer. J Korean Med Sci 2010; 25: 369–373.
10.
Khalaf IM, Shokeir AA, El-Gyoushi FI, Amr HS, Amin MM: Recoverability of renal function after treatment of adult patients with unilateral obstructive uropathy and normal contralateral kidney: a prospective study. Urology 2004; 64: 664–668.
11.
Kumar K, Ahmad A, Kumar S, Choudhry V, Tiwari RK, Singh M, Muzaffar MA: Evaluation of renal histopathological changes, as a predictor of recoverability of renal function following pyeloplasty for ureteropelvic junction obstruction. Nephrourol Mon 2015; 7:e28051.
12.
Hsi RS, Holt SK, Gore JL, Harper JD: Trends in followup imaging after adult pyeloplasty. J Urol 2014; 191: 1357–1362.
13.
Isoyama T, Iwamoto H, Inoue S, Morizane S, Hinata N, Yao A, Honda M, Sejima T, Takenaka A: Hydronephrosis after retroperitoneal laparoscopic dismembered Anderson-Hynes pyeloplasty in adult patients with ureteropelvic junction obstruction: a longitudinal analysis. Cent European J Urol 2014; 67: 101–105.
14.
Koca O, Kaya C, Ozturk MI, Gunes M, Gumrukcu G, Karaman MI: Analysis of expression of TNF-alpha and TGF-beta3 in intrinsic ureteropelvic junction obstruction. Bratisl Lek Listy 2013; 114: 498–502.
15.
Li ZZ, Zhao ZZ, Wen JG, Xing L, Zhang H, Zhang Y: Early alteration of urinary exosomal aquaporin 1 and transforming growth factor β1 after release of unilateral pelviureteral junction obstruction. J Pediatr Surg 2012; 47: 1581–1586.
16.
Rickard M, Lorenzo AJ, Braga LH: Renal parenchyma to hydronephrosis area ratio (PHAR) as a predictor of future surgical intervention for infants with high-grade prenatal hydronephrosis. Urology 2017; 101: 85–89.
17.
Salem YH, Majd M, Rushton HG, Belman AB: Outcome analysis of pediatric pyeloplasty as a function of patient age, presentation and differential renal function. J Urol 1995; 154: 1889–1893.
18.
Menon P, Rao KL, Bhattacharya A, Mittal BR: Outcome analysis of pediatric pyeloplasty in units with less than 20% differential renal function. J Pediatr Urol 2016; 12: 171.e1–e7.
19.
Tublin ME, Bude RO, Platt JF: Review. The resistive index in renal Doppler sonography: where do we stand? AJR Am J Roentgenol 2003; 180: 885–892.
20.
Ponte B, Pruijm M, Ackermann D, Vuistiner P, Eisenberger U, Guessous I, Rousson V, Mohaupt MG, Alwan H, Ehret G, Pechere-Bertschi A, Paccaud F, Staessen JA, Vogt B, Burnier M, Martin PY, Bochud M: Reference values and factors associated with renal resistive index in a family-based population study. Hypertension 2014; 63: 136–142.
21.
Boddi M, Natucci F, Ciani E: The internist and the renal resistive index: truths and doubts. Intern Emerg Med 2015; 10: 893–905.
22.
Bige N, Levy PP, Callard P, Faintuch JM, Chigot V, Jousselin V, Ronco P, Boffa JJ: Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease. BMC Nephrol 2012; 13: 139.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.